Desogestrel | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Desogestrel

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

22 API Suppliers, 8 USDMF, 6 CEP/COS, 4 JDMF, 2 EU WC, 4 NDC API, 13 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

120 FDF Dossiers, 32 FDA Orange Book, 61 Europe, 14 Canada, 4 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL-21 - 0.15MG;0.03MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL-28 - 0.1MG,0.125MG,0.15MG;0.025MG,0.025MG,0.025MG

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 10 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 51 Finished Drug Prices, 3 Annual Reports

MARKET PLACE

5 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 5 USP, 5 Others

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

3 All

01 1Cerazette

02 2Marvelon/Mercilon

List of Suppliers

Product Main Page

01

Brand Name : Cerazette

Fi Europe 2024

Not Confirmed

02

Brand Name : Marvelon/Mercilon

Fi Europe 2024

Not Confirmed

03

Brand Name : Marvelon/Mercilon

Fi Europe 2024

Not Confirmed

Contact us
to update this info